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Background Serotonin may contract human large coronary arteries through two 5-hydroxtryptamine (5-HT) receptors, 5-HT1-like and 5 -HT2. These 5-HT1-like receptors resemble both cloned 5-HT1D receptor subtypes, 5-HT'1D, and 5 -HT1Ds.
Although these subtypes have similar pharmacology, 5-HT1Dg receptors appear to have lower affinity for ketanserin than 5-HT1Di receptors. We assessed the relative participation of 5-HT1-like and 5-HT2 receptors and attempted to identify whether vasoconstrictor 5-HT1-like receptors are 5 1HTDa or 5-.HIlD .
Methods and Results Epicardial coronary arteries were dissected from the hearts of 29 patients (including 1 healthy donor) undergoing heart transplant operation. Endotheliumdenuded strips were set up to contract at 37°C. To assess the relative contributions of 5-HT,-like and 5-HT2 receptors, we blocked the latter with ketanserin (0.1 to 1.0 ,umol/L) and ketanserin-resistant receptors with methiothepin (0.1 ymol/ L). Concentration-effect curves for 5-HT, in the absence and presence of ketanserin, were analyzed by using a model for two receptor subtypes. The fractional contributions of 5-HT1-like and 5 -HT2 receptors to the maximum effect of 5 -HT, fl and f2,~t uman coronary artery can both relax"2 and El constrictl-3 in response to intracoronary sero-_L A. tonin (5-hydroxytryptamine, 5-HT). In patients with stable coronary artery disease, the normal dilator response disappears, and only progressive constriction is observed with serotonin.1'2 Evidence is accumulating for the participation of two distinct 5-HT receptors, 5 -HT,-like and 5 -HT2, in the human coronary constriction elicited by serotonin.'-3 The 5-HT2 receptor-selective antagonist ketanserin4,5 has been found to block effectively serotonin-evoked constriction in patients with atherosclerotic coronary arteries and stable angina.1 In another study, however, ketanserin only partially blocked serotonin-induced coronary constriction of epicardial segments in patients with stable angina.3 Furthermore, ketanserin failed to block serotonin-induced constriction of epicardial arteries in patients with variant angina.3 The ketanserin-resistant constriction of coronary arteries observed in patients with stable or variant angina suggests the involvement of 5-HT1-like receptors,3 which have low affinity for ketanserin.6 Support for a role of 5 -HT,-like receptors in coronary constriction has appeared with the clinical use of sumatriptan,7-10 introduced as a selective 5-HTI-like receptor agonist'l 12 to constrict cerebral arteries presumably dilated during migraine.'3 Both intravenous and subcutaneous administration of sumatriptan cause constriction of human large coronary arteries.7,8 Coronary spasm with angina,9 myocardial infarction,l4 and even ventricular fibrillation10 have also been reported with sumatriptan.
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Evidence gained from isolated human coronary arteries'5-'9 is consistent with the in vivo findings that serotonin causes contraction through both 5-HT1-like and 5-HT2 receptors. Although there is no disagreement about the potential ability of both 5-HT1-like and 5-HT2 receptors to mediate contraction, little is known about their relative participation. It has been claimed that serotonin-evoked contractions are predominantly mediated through 5-HT2 receptors and only to a minor extent through 5-HT1-like receptors.'5" 6'20 On occasion, however, regional differences have been reported within different segments of the same coronary artery with both marked ketanserin-sensitive and ketanserin-insensitive components,17"8 suggesting that 5-HT1-like receptors can sometimes be more important than 5 -HT2 receptors. Sumatriptan contracts isolated human coronary arteries only through 5 -HT,-like receptors,15"19 and its effects appear more pronounced in smooth muscle in the proximity of atheroma than distal from atheromatous lesions.'9 It is unknown, however, whether sumatriptan is a full agonist or partial agonist for constrictor 5-HT1-like receptors of human coronary artery.
The variability of the contribution of the two 5 -HT receptor subtypes as a function of disease is also unknown. We have therefore studied isolated epicardial coronary arteries obtained from 29 patients with a variety of clinical conditions. We present a quantitative analysis of the relative contributions of 5 -HT1-like receptors and 5 -HT2 receptors to serotonin-induced contraction. To selectively block 5-HT2 receptors, we used receptor-saturating concentrations (0.1 to 1.0 ,umol/L) of ketanserin.4'5 To block both 5-HT,-like and 5-HT2 receptors,6 we used a receptor-saturating concentration (0.1 ,mol/L) of methiothepin.6 To selectively stimulate contractile 5-HTI-like receptors, we used sumatriptan.1"'12"15"19 By comparing the estimated 5-HT,-like receptor fraction of serotonin-induced contraction with sumatriptan-induced contraction on the same coronary artery, we evaluated whether sumatriptan is a full agonist or partial agonist for these receptors.
Finally, we examined the nature of the constrictor 5-HT1-like receptors of human coronary artery. Arterial constrictor 5-HT1-like receptors resemble 5-HTID receptors, of which two subtypes, 5 -HT1Da21-23 and 5-HTlD, ,2"23-27 have been cloned. Both subtypes have remarkably similar pharmacology,23 but 5-HTlDa receptors appear to have higher affinity for ketanserin. 28 We have now verified this affinity difference in membranes obtained from cells containing these transfected and expressed receptors. To investigate which 5 -HT1D receptor subtype is involved in 5-HT-induced contraction of human isolated large coronary arteries, we carried out experiments using a ketanserin concentration (1 ,umol/L) that would be expected to block the effects of 5-HT only if they were mediated through 5 -HT1Da receptors.
We found that, on average, 5-HT1-like receptors are more important than S -HT2 receptors in mediating serotonin-evoked contraction. Based on resistance to blockade by 1 ,umol/L ketanserin, it is unlikely that serotonin-evoked contractions are mediated through 5-HTLDa receptors. Sumatriptan was consistently found to be a full contractile agonist for S -HT,-like receptors.
Methods Patients
Human coronary arteries were obtained from 29 human hearts. In 28 cases, the hearts were explanted from patients undergoing heart transplantation. In one case, the heart was from a donor who died from intracerebral bleeding. Diagnosis, age, and sex of the patients and medications before explantation are given in Table 1 .
Isolated Coronary Arteries
Large epicardial coronary arteries were dissected from fresh hearts and placed either in a modified oxygenated Krebs' solution at room temperature (16 patients in Cambridge laboratory and 4 patients in Dusseldorf laboratory) or in ice-cold Ringer's lactate solution (9 patients in Dusseldorf laboratory, Nos. 2, 4, 14, 15, 20, 22, 23, 26 , and 27 of Table 1 ) and transported to the laboratory. Arteries bathed in Ringer's lactate solution were later transferred into modified oxygenated Krebs' solution. The Ringer's lactate solution contained (mmol/L) Na+ 130, K' 5.3, Ca2' 1.85, Cl-112, lactate 27. The modified Krebs' solution contained (mmol/L) Na+ 120, K' 5, Ca2' 2.25, Mg 2+ 0.5, Cl-98.5, SO42-0.5, HCO3-29, HPO32-1, and EDTA 0.04, equilibrated with 95% 02/5% C02. The water was deionized and redistilled in glass.
The coronary artery was cleared of fat and connective tissue. Up to 24 helicoidal strips were cut, and the endothelium was removed by gently rubbing the lumen surface with a paper towel. The strips were mounted, usually in pairs, in an apparatus29 with a 50-mL organ bath containing the modified Krebs' solution described above complemented with (mmol/L) Na+ 20, fumarate 5, pyruvate 5, L-glutamate 5, HCO3-5, and glucose 10. The solution also contained (,umol/L) cocaine 6 (to block tissue capture of serotonin30), prazosin 1 (to block a1-adrenoceptors), and ascorbate 200 (to retard oxidation of serotonin30). The strips were attached to strain-gauge transducers connected by amplifiers to polygraphs. Resting force was adjusted to approximately 20 mN at the beginning of an experiment, and the strips then were left at the corresponding length throughout the experiment. Tension was measured isometrically. High potassium contractures were elicited through depolarization with a modified Krebs' solution, in which 137 mmol/L Na+ was replaced by 137 mmol/L K'.
Particular attention was paid to the existence of stenosis and atheroma.18 Whenever possible, prestenotic and poststenotic segments were set up in pairs in the same organ bath. Neighboring segments with and without atheroma also were set up in pairs in the same organ bath. Finally, segments of artery close to a stenosis or atheroma were set up in the same organ bath with segments distal to the stenosis or atheroma.
After strips of artery had been set up at 37°C, at least two high-KCl contractures were evoked. The strips were then allowed to relax for 8 hours at room temperature before the temperature was again increased and then left at 37°C. The tissues were repeatedly challenged with high KCI until two successive contractures developed reproducible force. The tissues then were briefly exposed to a maximally effective concentration of serotonin (10 ,umol/L). After washout of serotonin and another KCl contracture, a single concentration-effect curve was estimated for either serotonin or sumatriptan. Antagonists were incubated for at least 90 minutes before starting a concentration-effect curve. Control strips with an agonist concentration-effect curve in the absence of an antagonist were always run simultaneously. The contractile effects of serotonin and sumatriptan were measured either from tonic contractions or by integrating phasic contractions using a digitizing tablet linked to a PC computer and analyzed using SigmaScan software (Jandel). The latter method was used in tissues showing pronounced phasic contractions before and/or in response to serotonin or sumatriptan. From a total of 258 tissues, 37 (14%) showed spontaneous phasic contractions before exposure to 5-HT or sumatriptan. In 4 patients we observed no spontaneous activity at any time. In one case (patient 14 of Tables 1 and 2) , phasic contractions were too slow and inconsistent for meaningful analysis. 
Binding Studies
Binding assays on cloned human 5 -HTlD, and 5 -HTIDe receptors were carried out essentially as described.22
Cloned human 5 HT1D,a receptors were assayed in membranes prepared from transiently transfected HEK 293 cells expressing about 25 000 receptors per cell. Cells were harvested and washed in phosphate-buffered saline (PBS), collected by centrifugation, frozen in dry ice/ethanol, and stored at -70°C. The PBS contained (mmol/L) 2.7 KCI, 1.5 KH2PO4, 137 NaCI, 8.1 Na2HPO4. Membranes were prepared as follows. Cell pellets were thawed and homogenized at 4°C using a Polytron (20 seconds at position 8) followed by 20 strokes in a hand-held glass-in-glass (dounce) homogenizer. The medium used for homogenization contained (mmol/L) 10 MgSO4, 0.5 EDTA, 50 Tris-Cl (pH 7.7), 24 pug/mL DNAse I (Sigma). The homogenate was centrifuged at 186 OOOg for 40 minutes, the pellet was resuspended in the same medium without DNAse, and the centrifugation was repeated. The resulting pellet then was resuspended in the same medium (no DNAse) containing 0.25 mol/L sucrose; aliquots (100 ,uL) were frozen in dry ice/ethanol and stored at -70°C.
Cloned human 5-HT1Dp receptors were assayed in homogenates of stably transfected Chinese hamster ovary cells expressing about 30 000 receptors per cell. The cells were harvested and washed in PBS, collected by centrifugation, and the pellets were transferred to a -70°C freezer for storage.
On the day of the experiment, the cell pellets or membranes were thawed and homogenized at 4°C in a hand-held glass-inglass (dounce) homogenizer (20 strokes) in incubation medium containing (mmol/L) 50 Tris-Cl (pH 7.7 at 20°C), 10 MgSO4, 0.5 EDTA, 0.2 ascorbic acid, 0.1 pargyline. Aliquots Potency values (-log ECw, mol/L) were estimated from concentration-effect curves (cec) for serotonin and sumatriptan. 5-HT1 and 5-HT2 are potency values of serotonin for effects mediated through 5-HT1-like receptors and 5-HT2 receptors respectively, calculated from fits using the two-receptor model (see "Methods"). Methio indicates potency estimate for serotonin in the presence of 100 nmol/L methiothepin; Log CR, log concentration ratios of serotonin in the presence and absence of 100 nmol/L methiothepin, e ted as differences between the corresponding serotonin -log EC50 values. fl denotes the fraction of serotonin-evoked contractos mediated through 5-HT1-ike receptors. The relative potency shows the ratio of ECw values for serotonin and sumatriptan. of this homogenate then were distributed to the assay tubes. Assays (final volume, 0.5 mL) were carried out in incubation medium together with [3H]-5-HT (3 to 5 nmol/L), competing ligand at indicated concentrations, and cell membranes (5-HTlDa, membranes from about 2x106 cells per assay tube; 5-HTlD, homogenate from about 107 cells per assay tube).
Nonspecific binding was defined using 10 gmol/L serotonin.
Incubations were for 45 minutes at 370C, after which the contents were filtered on Whatman GF/B filters usimg a Brandel harvester and washed three times with 3 mL ice-cold incubation medium. [3H' on the filters was determined by liquid scintillation counting.
Data Analysis and Statistics Coronary Arteries
Where possible, data for serotonin in the absence and presence of ketanserin were fitted to a two-receptor model by nonlinear regression using GRAFIT. 31 One of the receptors (5-HI2) was assumed to be competitively blocked by ketan- .''-:li"" -,.-.,. '., .,-. i. .
(1) where K, is EC50 of 5-HT for 5-HT,-like receptors, K2 is EC_o of 5 -HT for 5-HT2 receptors, fl is maximal effect mediated through 5-HT1-like receptors, and f2 is maximal effect mediated through 5-HT2 receptors. Data with serotonin, obtained in the absence and presence of ketanserin, were analyzed simultaneously to give an overall fit for the experiment.
After fitting the data for a particular experiment, the values of fl and f2 were generally multiplied by the maximum response for each condition to superimpose the fitted curves on the original data. Concentrations of serotonin and sumatriptan producing half-maximal responses (EC_%, mol/L) were estimated, and these values as well as the K, and K2 values from concentration-effect curves of serotonin in the presence and absence of the antagonist. Because regional differences were usually small, data from several arterial segments were generally pooled for a given experimental condition. Only in three cases did we detect a marked regional deviation when outlier tissues were excluded from average tissue groups (Fig 5) .
Unless otherwise stated, data are expressed as mean±SD. 
Materials
Serotonin was purchased from Sigma (5 -hydroxytryptamine HCI). Ketanserin tartrate was a gift from Janssen. Methiothepin HCl was a gift from Hoffmann-LaRoche. Sumatriptan and 5-carboxamidotryptamine were synthesized by chemists of SmithKline Beecham. [3H]-5-HT, specific activity 840 GBq/mmoL, was purchased from DuPont (NEN) and cocaine from Merck. Prazosin was a gift from Pfizer.
Results

Phasic and Tonic Contractions
In agreement with previous reports,35,36 some coronary artery strips spontaneously developed phasic contractions. The force generated by these contractions was usually smaller than that induced by KCI or serotonin. Neither methiothepin nor ketanserin affected the char-
Pattern of blockade by ketanserin and methiothepin of phasic and tonic serotonin-evoked contractions. The original recordings demonstrate four segments of circumflex coronary artery obtained from patient 3 of Table 1 . Concentration-effect curves for serotonin were simultaneously determined in the absence of antagonists (two upper tracings) or in the presence of antagonist as demonstrated. Note that ketanserin, although slightly inhibiting the effects of serotonin, did not change the pattern of contractions, whereas methiothepin caused much more pronounced blockade and eliminated phasic contractions. Calibration was the same for all segments.
acteristics of spontaneous phasic contractions (not shown). Serotonin caused phasic and tonic contractions ( Fig  1) . Ketanserin caused variable and inconsistent blockade of serotonin-evoked phasic or tonic contractions but did not change its pattern (Fig 1) . Methiothepin consistently blocked serotonin-induced contractions; usually only tonic contractions occurred at the high serotonin concentrations needed to surmount the effect of methiothepin (Fig 1) .
Relative Contributions of 5-HT1-Like Receptors and 5-HT2 Receptors to Ischemic Heart Disease
Serotonin contracted helicoidal strips of coronary artery in a concentration-dependent manner with a -log EC5o (mol/L) of 6.98+0.31 (n=13 patients, using data from both prestenotic and poststenotic strips for patient 13; see Table 2 ) (Fig 2) . Ketanserin (100 to 1000 nmol/L) caused inconsistent antagonism of serotonininduced contractions, which was usually completely surmounted by high serotonin concentrations. When shifted to the right by ketanserin, concentration-effect curves to serotonin were biphasic or flatter than in the absence of ketanserin. The contribution of 5-HT1-like receptors was assessed from the fraction f1 of the maximum serotonin response and that of 5-HT2 receptors from f2 (see "Methods"). Despite large variability (range of fl=0.19 to 1.0), fl was nearly twice f2 on average (fl=0.65+0.24, f2=0.35+0.24; mean±SEM, n= 12; P< .05) ( Table 2) (Table 1) is indicated in a square on each panel. Calculated f1 fractions according to Equation 1 are indicated. n=1 to 4 segments for each curve; SEM is shown if n>2. participation of 5 -HT,-like receptors. The 5 -HT, nature of the ketanserin-resistant receptors received support from the blockade caused by methiothepin 100 nmol/L, which in 5 patients shifted the serotonin concentration-effect curve to the right by 2.07±0.58 log units ( Table 2) .
Congestive Cardiomyopathy
Serotonin caused contractions with a -log EC50 (mol/L) of 6.80±0.29 (n=10 patients, No. 14 being excluded; see "Methods") ( Fig 3 and Table 2 ). As in ischemic heart disease, ketanserin caused variable and inconsistent blockade. f1 was estimated to be 0.74±0.17 and f2, 0.26±0.17 (P<.01), suggesting predominance of 5 -HT1-like receptors over 5 -HT2 receptors. In 5 of the patients, and consistent with an important involvement of 5-HT1-like receptors, methiothepin blocked serotonin-induced contraction, shifting the serotonin concentration-effect curve by 2.02±0.46 log units.
Miscellaneous
Serotonin contracted arteries from 2 patients with congenital heart disease (Fig 4) with -log EC_% (mol/L) of 6.69 and 7.87 and fl values of 0.86 and 0.77. In arteries from 2 patients with rheumatic valve disease ( Table 2) , -log EC50 (mol/L) values of 6.06 and 6.97 and f1 values of 0.85 and 0.67 were obtained; in the first of these, methiothepin 100 nmol/L shifted the serotonin concentration-effect curve by 1.19 log units. In arteries of the healthy donor, the -log EC50 (mol/L) for serotonin was 6.59 and fl was 0.89 ( Table 2 ).
Influence of Atheroma and Regional Differences It has been suggested that the relative contributions of 5 -HT,-like and 5 -HT2 receptors to serotonin-induced contractions depend on the location relative to stenosis or atheroma. [17] [18] [19] In prestenotic atheromatous strips, a large ketanserin-resistant fraction (5-HT1-like receptors) and in poststenotic nonatheromatous strips a large ketanserin-sensitive fraction (ie, 5-HT2 receptors) of serotonin-induced contraction was detected. 18 For the artery that displayed this phenomenon, fl was 0.80 in the prestenotic strips and 0.20 in the poststenotic strips ( Fig 5, patient 13 ). However, this pattern was not observed in arteries from any of the other 12 patients with ischemic heart disease. Strips from prestenotic and poststenotic areas, with or without atheromatous sequelae, were often remarkably similar in the relative contributions of ketanserin-sensitive and ketanserinresistant components of serotonin-induced contractions (eg, Fig 5, patient 8 ). However, regional differences were occasionally observed not only in atherosclerotic coronary arteries but also in macroscopically intact coronary arteries derived from congestive cardiomyopathy ( Fig 5, patient 21 ) or complex congenital heart disease (Fig 5, patient 26 ). 
Sumatriptan-Evoked Contractions
Like serotonin, sumatriptan usually caused a mixture of tonic and phasic contractions. In patient 23 of Tables  1 and 2 , however, both sumatriptan and serotonin only elicited tonic contractions; the maximum effect of sumatriptan was 69% of that of serotonin. Sumatriptan contracted human coronary arteries with a potency (-log ECso [mol/L] of 6.61±0.39, data from 8 patients including donor) similar to that of serotonin. In patients with serotonin-induced contractions mostly resistant to ketanserin, sumatriptan tended to be more effective (compare sumatriptan data of Fig 6 with data of the corresponding patients in the presence of ketanserin in Figs 2 and 3; also see Table 2 ). The maximum response to sumatriptan, expressed as a fraction of the maximum response to serotonin, correlated with the f1 fraction estimated from data obtained from the same arteries (Table   3 ). Ketanserin inhibited [3H]-5-HT binding to 5-HT1Da receptors with a p1C50 (mol/L) of 6.7, corresponding to a pKi of 7.1. At 5-HTID, receptors, ketanserin at concentrations up to i0-5 mol/L had little effect on [3H]-5-HT binding.
Discussion
Predominance of 5-HT1-Like Receptors Over 5-HlT2 Receptors
We show for the first time that although interpatient variability is large, 5-HT1-like receptors appear to be more important than 5-HT2 receptors in mediating serotonin-evoked contraction of large coronary arteries. In arteries of 28 patients including one donor, the fraction of maximum serotonin-evoked contraction mediated through 5-HT1-like receptors (71% on average) was significantly greater than that mediated through 5-HT2 receptors (29%) (P<.0001) ( Table 2 ). In arteries from 9 patients and from the donor, 85% or more of the (Table 1) is shown in a square on each panel. Patient 13: The only example of differing f1 fractions in strips prepared from a prestenotic (A) and poststenotic (B) region; the segments were from a circumflex coronary artery of a patient with ischemic heart disease, n=2 for each condition. serotonin-evoked contraction was mediated through 5-HT1-like receptors. In coronary arteries from only 4 out of 27 patients did 5 -HT2 receptors mediate more than 50% of the maximum serotonin-evoked contraction. The fractional participation of 5-HT,-like receptors and 5 -HT2 receptors was assessed with the help of ketanserin (0.1 to 1.0 ,umol/L). In coronary arteries from 11 patients, the ketanserin-resistant component (ie, not mediated through 5-HT2 receptors) was potently antagonized by methiothepin (0.1 ,umol/L caused a 100-fold concentration ratio of serotonin, Table 2 Interestingly, ketanserin-sensitive (ie, 5-HT2 receptors) and ketanserin-resistant (ie, 5-HT1-like receptors blocked by methiothepin) contractile receptors also have been described in isolated canine large coronary arteries,37-40 and the canine contractile 5-HT1-like receptor may be a species homologue of the contractile 5-HT,-like receptor (probably 5-HT1D.) of human large coronary artery.40 Canine coronary arteries, denuded of endothelium, are also relaxed by high serotonin concentrations through a receptor located on smooth muscle and blocked by methiothepin.3940 We only detected small and inconstant relaxations of human coronary arteries with high serotonin concentrations (Figs 2 and  3) , and it is not yet clear whether they are mediated through a 5-HT receptor homologous to the canine relaxant receptor.
Our findings of a predominance of 5 -HT,-like receptors in the mediation of serotonin-evoked contraction of large coronary artery are at variance with the conclu- sion of previous studies, which claimed that 5-HT2 receptors predominate. 15, 16, 19 One study based this conclusion on results obtained from only 4 patients, and even in these, 5-HT1-like receptors appear to have mediated approximately 40% of the serotonin-evoked contraction.'s This is perfectly in line with similar estimates in arteries from some but not the majority of our patients.
In another study, using coronary artery preparations obtained from autopsies of 9 patients, ketanserin pro- duced nonparallel shifts of concentration-effect curves for serotonin. 16 The curves in the presence of ketanserin were more rightward shifted at high concentrations of serotonin than at low concentrations but were incomplete, so that no precise estimate could be made of the relative contributions of ketanserin-sensitive (5 -HT2) and ketanserin-insensitive (5-HT1-like) receptors. 16 Interestingly, maximum contractile effects of the 5-HT1like receptor agonist 5-carboxamidotryptamine (5-CT) were moderately reduced by ketanserin 1 ,umol/L, but the sensitivity of the coronary arteries to 5-CT (EC50) was unchanged,16 suggesting some involvement of 5-HT2 receptors. Based on the maximum effect of sumatriptan, Chester et a141 claimed that 5-HT1-like receptors mediate about 30% of 5-HT-induced contraction. They did not observe differences in this estimate between apparently normal coronary arteries from 11 young patients (average age, 24 years) and coronary arteries from 10 patients (average age, 53 years) with ischemic heart disease.19 However, Chester et al did not estimate the fraction of maximum serotonin response mediated through 5-HT1-like receptors and so did not assess whether sumatriptan was a full agonist. The discrepancy between our data and the conclusion of Chester et al is unlikely to be related to differences in age and disease of the patients. For example, the 4 patients in our study with fl fractions smaller than 0.5 (patients 10, 11, 12, and 24 of Tables 1 and 2) were on average 44 years old, and 3 of these had ischemic heart disease. Similarly, the 12 patients with ischemic heart disease in the present work had a mean age of 51 years, very similar to that in the study of Chester et al, but a mean fl fraction of 0.65.
In another study on coronary arteries from 5 to 9 individuals,20 ketanserin appeared to block the effects of serotonin more (but not completely) than in our series of coronary arteries from 28 patients. The authors concluded that in addition to 5 -HT2 receptors, other receptors contribute to serotonin-evoked contractions.20 These authors used arteries obtained both from heart transplants and postmortem hearts,20 and it is not clear which were used for the few experiments with ketanserin. As in the other study with coronary arteries obtained after death, 16 5-HT,-like receptors may be less robust than 5 -HT2 receptors to survive after death, thereby possibly distorting the true condition of arteries freshly dissected from live hearts.
Sumatriptan Is a Full Agonist for 5-HT1-Like Receptors in Human Coronary Artery
Comparison of estimated fractions of serotoninevoked contractions mediated through 5 -HT,-like receptors with the maximum sumatriptan-evoked contraction revealed that sumatriptan is a full agonist for 5-HT,-like receptors in human coronary artery (Fig 7) .
In agreement with previous studies,15,'9 ketanserin 0.1 ,umol/L failed to block the sumatriptan-evoked contractions in coronary arteries obtained from 2 patients, ruling out an interaction with 5 -HT2 receptors. Furthermore, sumatriptan-evoked (ie, ketanserin-resistant) contractions are surmountably antagonized by methiothepin,19 as expected from an interaction with 5-HT1like receptors. Sumatriptan was also a potent full agonist in the coronary artery obtained from the donor heart with 89% of the serotonin-evoked contraction recently been cloned as well as the human homologue of the 5HT7 receptor.54 Is one of these receptors the coronary constrictor 5-HT1-like receptor? To answer this question with the available data, we must compare the properties of the coronary constrictor 5-HT1-like receptor with affinity estimates for the cloned 5-HT receptors ( Table 3 ). We have measured three properties of human coronary arteries relevant in this comparison: (1) Table 3 ). The affinity of methiothepin for the 5-HT1E receptor is about 1000 times lower45-47 than for constrictor 5-HTI-like receptors in large coronary arteries. Furthermore, the 5-HT1E receptor has also low affinity for 5-CT. [45] [46] [47] These properties, taken together, exclude both 5-HT1A and 5-HT1E receptors as candidates for coronary constrictor 5-HT1-like receptors. The moderately high potency of sumatriptan on coronary constrictor 5-HT1-like receptors (-log EC50 [mol/L]=6.6, Table 2 ) is similar to its affinity for the 5-HT1F receptor (-log KD=7.6,48 see Table 3 ). However, the affinity of methiothepin for the 5-HT1F receptor is about 1000 times lower than its blocking potency on human coronary artery, and the affinity of 5-CT is also lower than its potency at the coronary constrictor 5-HT1-like receptor. These data are inconsistent with an identity of the two receptors ( Table 3 ).
The 5-HT5 receptor subtypes exhibit low affinity for sumatriptan and serotonin and only moderate affinity for methiothepin (Table 3) , properties inconsistent with the characteristics of human coronary artery constrictor 5-HT1-like receptors. The 5-HT6 and 5-HT7 receptors are more difficult to exclude on the basis of pharmacology alone (Table 3) , although the relatively high affinity of the 5-HT7 receptor for ketanserin together with its markedly lower affinity for sumatriptan compared with serotonin and 5-CT make this a less likely candidate for the 5-HT,-like receptor. More importantly, however, both 5-HT6 and 5-HT7 receptors are positively linked to adenylyl cyclase,51-54 and agonist stimulation would therefore be expected to cause relaxation rather than contraction of smooth muscle. It is therefore unlikely that the contractile 5-HTI-like receptor corresponds to either 5 -HT6 or 5 -HT7 subtype.
The pharmacology of 5 -HT1D, and 5 -HTlD is remarkably similar despite pronounced structural differences.
Both 5-HT1D receptor subtypes exhibit high (nanomolar) affinity for methiothepin and relatively high affinity (pKi=7.5 to 8.0) for sumatriptan. Serotonin is only slightly more potent than sumatriptan as an agonist on 5-HT1D receptors (inhibition of forskolin-stimulated adenylyl cyclase)24 and equipotent with sumatriptan at the 5-HTlDa receptor.23 These characteristics, taken together, would suggest that both 5 -HTlD, and 5 -HT1DP receptors resemble coronary constrictor 5-HT1-like receptors. However, the 5-HTlDa receptor has a greater than 70-fold higher affinity for ketanserin than the 5-HT1D# receptor,2, as verified by us (Fig 8 and Table 3 ). If the coronary constrictor 5 -HT,-like receptor were 5-HTlDa (pKi for ketanserin=7.1), we should have observed a shift by 1.1 log unit in the concentration-effect curve for serotonin by 1 ,umol/L ketanserin. However, in coronary arteries obtained from 4 patients, 1 ,umol/L ketanserin virtually failed to cause any blockade. By exclusion, the 5 -HTlDa, receptor is a less likely candidate than the 5 -HTlDp receptor for the human coronary artery constrictor 5-HT1-like receptor. Clinical Implications A major finding of the present study is that in spite of huge variability of the relative participation of 5-HT1like and 5-HT2 receptors to serotonin-evoked contraction, no systematic influence of disease could be observed. Furthermore, the potencies of serotonin and sumatriptan as well as the relative contributions of 5-HT,-like and 5-HT2 receptors were not significantly altered by any medication. Contractile effects of serotonin in essentially healthy coronary arteries (from patients with congestive cardiomyopathy or congenital heart disease and from the donor heart) had a similar contribution of 5-HT1-like receptors (fl=0.76±0.16, n= 13 patients) as those in severely stenotic atherosclerotic coronary arteries (fl=0.65+0.24, n=12 patients). Thus, both constrictor 5-HT1-like and 5-HT2 receptors do obviously preexist, and their relative ratio is not necessarily modified by atheroma. Are there regional differences related to atherosclerotic lesions in the responses to serotonin in the coronary arterial vasculature? Kaumann and Brown17'18 reported such a difference in strips from one patient with ischemic heart disease. Proximal and distal to a subtotal stenotic lesion, serotonin caused contraction predominantly through 5-HT,-like and 5-HT2 receptors, respectively. We have included and reanalyzed data from that patient in the present series (patient 13 of Tables 1 and 2) and estimated a prestenotic f,=0.81 and a poststenotic f1=0.20 (Fig 5) . It is not clear whether this difference in prestenotic and poststenotic f1 values is related to atheroma or stenosis itself.
Chester et al19 observed in a small number of experiments (3 patients) that sumatriptan was more effective near an atherosclerotic plaque than more distal in the same artery, suggesting that S-HT.-like receptors are more important close to than distal from atheroma. In the present study we evaluated data from a large number of patients but detected no systematic regional differences caused by atherosclerotic plaques and stenotic lesions. On the contrary, even in macroscopically healthy coronary arteries, some unexpected regional variations in the ratio of 5-HT1-like and 5-HT2 receptors were occasionally observed without any relation to stenoses (Fig 5, patients 21 and 26 ).
Intracoronary thrombus formation may sensitize 5-HT receptor systems to enhance serotonin-evoked spasm through synergy with thromboxane A2, coreleased with serotonin from aggregating platelets. 36'55'56 Consistent with previous experiments with canine coronary artery flow,56 it has recently been shown that some preconstriction of isolated human coronary arterial rings with a thromboxane A2 agonist enhances the constrictor efficacy of serotonin. 36 The constrictor efficacy of sumatriptan is also enhanced by the thromboxane A2 agonist, suggesting that 5 -HT,-like receptors are involved in the synergy. 36 There is experimental evidence for a contribution of serotonin in the genesis of coronary spasm,57 especially when the endothelium becomes damaged.58'59 An involvement of serotonin in Prinzmetal's variant angina also cannot be ruled out despite the failure of ketanserin to produce beneficial effects at concentrations that block 5 -HT2 receptors in platelets.60 In view of the marked contractile effects of serotonin mediated through 5-HT,-like receptors in human large coronary artery reported in the present study, the possible role of endogenous serotonin in Prinzmetal's variant angina should be reinvestigated using an antagonist of 5-HT1like receptors.
In addition to pathophysiological factors, iatrogenic factors also may cause coronary artery constriction and spasm, as recently observed clinically with sumatriptan.7-10 14Our results, demonstrating that sumatriptan is practically a full agonist at 5-HT,-like receptors of human large coronary artery, are consistent with the clinical evidence. Of particular relevance is our observation on coronary arteries of the healthy donor heart, which showed a large fl fraction (f,=0.89) and on which sumatriptan was an even more potent agonist than serotonin. The experiment agrees with a recent observation that sumatriptan can cause coronary constriction leading to infarction in an individual without previous heart disease.14 These observations, taken together, raise the question of the safety of sumatriptan treatment not only in patients with cardiovascular disease but even in apparently healthy people.
We conclude that in human large coronary artery (1) both S-HT,-like and S-HT2 receptors mediate serotonin-evoked contractions, the former receptors more than the latter, (2) the antimigraine agent sumatriptan is a full contractile agonist through 5-HT1-like receptors, and (3) the contractile 5-HT,-like receptors resemble more cloned human 5-HTl1D, receptors than 5-HTlDa receptors. human 5 -HT1D, and 5 -HT1Dp receptors and Brian Bond (SmithKline Beecham) for advice with statistical analysis.
